Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Possibilities for cardiovascular gene therapy].

Zsolt László Szelid1, Peter Pokreisz, Stefan Janssens

  • 1Gottsegen Györgyi Országos Kardiológiai Intézet, Budapest.

Orvosi Hetilap
|July 7, 2005
PubMed
Summary

Gene therapy offers a promising alternative for cardiovascular diseases, potentially overcoming limitations of traditional drugs and improving heart function. This approach aims for long-term cardio-protection by delivering therapeutic genes directly to damaged heart cells.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiovascular, limb, and kidney effects of SGLT2 inhibitors in patients with peripheral artery disease: a systematic review and meta-analysis of randomized controlled trial data.

Cardiovascular diabetology·2026
Same author

Chronic quercetin supplementation modulates cardiac function and signaling pathways in aged male Wistar rat hearts subjected to ischemia-reperfusion.

Frontiers in cardiovascular medicine·2026
Same author

The prognostic value of systemic inflammatory response index (SIRI) in acute coronary syndrome patients treated with primary percutaneous coronary intervention: a meta-analysis and systematic review.

Clinical research in cardiology : official journal of the German Cardiac Society·2026
Same author

Integrated multi-modal data analysis for computational modeling of healthy and location-dependent myocardial infarction conditions in porcine hearts.

PLoS computational biology·2026
Same author

From Fiber Architecture to Functional Attachment: A Clinically Relevant, Mechanically Tunable Cardiac Patch.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

Beta-3 Adrenoreceptor Agonist Mirabegron Improves Right Ventricular Function in a Rat Monocrotaline-Induced Pulmonary Hypertension Model.

Pulmonary circulation·2026

Area of Science:

  • Cardiovascular Medicine
  • Molecular Biology
  • Gene Therapy

Context:

  • Atherosclerotic coronary artery disease remains a leading cause of death globally.
  • Current pharmacotherapies for ischemic heart disease have limitations in long-term cardio-protection and patient compliance.
  • Gene transfer protocols have shown advancements in treating various cardiovascular conditions.

Purpose:

  • To review the significance of gene-based approaches for cardiovascular diseases.
  • To discuss lessons learned from animal studies in gene therapy for heart conditions.
  • To explore the future clinical applications of gene-based cardiovascular strategies.

Summary:

  • Gene-based therapy presents a novel strategy for cardiovascular diseases, offering potential for site-specific treatment and prolonged therapeutic effects.

Related Experiment Videos

  • Gene transfer can overcome the need for frequent drug administration, addressing compliance issues associated with traditional pharmacotherapies.
  • While promising, gene therapy's benefits must be weighed against potential inflammatory side effects.

    • Impact:

    • Gene therapy could revolutionize cardiovascular disease management by providing durable cardio-protection and enhancing left ventricular function.
    • This approach may offer a more effective and compliant treatment option for patients with chronic ischemic heart disease.
    • Further research and clinical translation of gene-based strategies hold significant potential for improving patient outcomes in cardiovascular medicine.